Flexible quantities, fast turnaround, and deep chemistry expertise for every stage of your biotech pipeline.
Biotech companies operate under unique constraints: tight budgets, aggressive timelines, and the need for flexible quantities that scale with your pipeline. ChemContract understands these dynamics. We supply discovery-stage milligram quantities with the same rigor we bring to clinical-scale campaigns, so you never have to switch suppliers as your program advances.
Our team of 500+ scientists collaborates directly with biotech R&D groups on route design, hit-to-lead optimization, and custom analog synthesis. Whether you are a seed-stage startup or a publicly traded life sciences company, we provide the chemical backbone your research depends on.
Rapid synthesis of novel analogs, tool compounds, and SAR libraries to accelerate your hit-identification and lead-optimization programs.
Medicinal chemistry support including ADMET-guided design, multi-parameter optimization, and systematic exploration of chemical space around your leads.
Seamless transition from bench to kilo-lab to pilot plant. Process development and optimization ensure cost-efficient manufacturing as your program advances.
Diverse and focused compound libraries designed for high-throughput screening, fragment-based drug discovery, and phenotypic assay campaigns.
Small-quantity custom compounds for discovery research with no minimum order requirements.
→ 02Embedded chemistry teams for hit-to-lead, lead optimization, and preclinical candidate selection.
→ 03Compound characterization, purity determination, and structure confirmation for your leads.
→ 04High-throughput library generation for phenotypic screens and target-based drug discovery.
→Yes. We have no minimum order requirement and routinely supply milligram quantities for discovery-stage programs. Our pricing is transparent and competitive for small-scale work, and we offer flexible payment terms for startup clients. As your program scales, we grow with you without the need to requalify a new supplier.
For straightforward analogs of known chemotypes, typical turnaround is 2-4 weeks. More complex multi-step syntheses may require 4-8 weeks. We offer expedited services for time-critical programs and will provide a realistic timeline before work begins so you can plan your screening schedule accordingly.
Absolutely. We execute mutual CDAs before any proprietary information is shared and maintain strict IP protection protocols across all facilities. Your chemical structures, synthetic routes, and project data remain confidential. We have extensive experience working under biotech-specific IP frameworks and are happy to accommodate your legal requirements.
From first-generation analogs to clinical-scale supply, ChemContract is the chemistry partner biotech companies trust. Tell us about your project.
Hi there! How can we help you today?